FluoroquinolonesAnti-Infective AgentsContraceptives, Oral, SyntheticCiprofloxacinOfloxacinAnti-Bacterial AgentsMicrobial Sensitivity TestsDNA GyraseAza CompoundsLevofloxacinDrug Resistance, BacterialDNA Topoisomerase IVDesogestrelQuinolonesNorfloxacinNorpregnenesPefloxacinNaphthyridinesContraceptives, Oral, CombinedQuinolinesUreterolithiasisDrug Resistance, Multiple, BacterialEnoxacinDrug Resistance, MicrobialCephalosporins4-QuinolonesDNA Topoisomerases, Type IIContraceptives, OralGram-Negative BacteriaThromboembolismStreptococcus pneumoniaeDermatitis, Phototoxicbeta-LactamasesNalidixic AcidTopoisomerase II InhibitorsGram-Negative Bacterial InfectionsHepatitis C AntibodiesAromatase InhibitorsMacrolidesMutationFleroxacinStaphylococcus aureusRisk FactorsMycoplasma hominisEscherichia colibeta-LactamsClostridium difficilePneumococcal InfectionsBacterial InfectionsTyphoid FeverMycobacterium fortuitumHepatitis CNitrofurantoinDNA, BacterialAminoglycosidesPseudomonas aeruginosaTime FactorsGram-Positive BacteriaTreatment OutcomeCapreomycinAntitubercular AgentsCommunity-Acquired InfectionsDrug Resistance, MultipleBacterial ProteinsDrug UtilizationUrinary Tract InfectionsPedigreeEscherichia coli InfectionsPrevalenceEnterocolitis, PseudomembranousCase-Control StudiesParatyphoid FeverCohort StudiesNeisseria gonorrhoeaeCross InfectionAnti-Infective Agents, UrinarySalmonella typhiLaurusProspective StudiesBartonella bacilliformisMycobacterium tuberculosisGram-Positive CocciRetrospective StudiesCampylobacterGram-Positive Bacterial InfectionsMoraxella (Branhamella) catarrhalisOtitis ExternaGonorrheaRespiratory Tract InfectionsInfant, NewbornKlebsiella pneumoniaeSalmonella paratyphi ASalmonella entericaBacteria, AnaerobicTrimethoprim-Sulfamethoxazole CombinationTetracyclinesCampylobacter InfectionsCarbapenemsbeta-Lactam ResistanceExtensively Drug-Resistant Tuberculosis